# LAMOTRIGINE
> **ANDA217278** · Abbreviated New Drug Application (Generic) · Sponsor: ALEMBIC · Approved 2026-02-25
## Drug
- **FDA Application Number:** ANDA217278
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** LAMOTRIGINE
- **Generic name:** LAMOTRIGINE
- **Active ingredients:** LAMOTRIGINE
- **Dosage form:** TABLET, ORALLY DISINTEGRATING
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** ALEMBIC
- **Manufacturer:** Alembic Pharmaceuticals Inc.
- **First approval:** 2026-02-25
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217278)
---
*AI Analytics · CC0 1.0*